Performance of sFlt-1/PlGF ratio ≥85 for ruling in preeclampsia within 4 weeks

Performance of sFlt-1/PlGF ratio ≥85 for ruling in preeclampsia within 4 weeks

Objective Preeclampsia (PE) is a complex and heterogeneous disorder of pregnancy. Current clinical diagnostic criteria are nonspecific and correlate poorly with adverse fetal and maternal outcomes. The recently introduced angiogenic biomarkers soluble fms-like tyrosine kinase-1 (sFlt-1) and placenta...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Cerdeira, AS, O’Sullivan, J, Ohuma, EO, James, T, Papageorghiou, AT, Knight, M, Vatish, M
Format:	Journal article
Język:	English
Wydane:	Elsevier 2020

Podobne zapisy

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
od: Viktorija Tarasevičienė, i wsp.
Wydane: (2016-01-01)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
od: Anca-Florina Tataru-Copos, i wsp.
Wydane: (2022-09-01)

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
od: Zeisler, H, i wsp.
Wydane: (2016)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
od: Ioakeim Sapantzoglou, i wsp.
Wydane: (2023-06-01)

Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
od: Laura Ehrlich, i wsp.
Wydane: (2017-04-01)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
od: Sama Hussein, i wsp.
Wydane: (2022-12-01)

The role of sFlt1/PlGF ratio in the assessment of preeclampsia and pregnancy-related hypertensive disorders
od: Jonathan Baert, i wsp.
Wydane: (2021-07-01)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
od: Dietmar Schlembach, i wsp.
Wydane: (2018-08-01)

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia.
od: Evelyn Klein, i wsp.
Wydane: (2016-01-01)

The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
od: Risa Miyatake, i wsp.
Wydane: (2023-01-01)

Predictive value of the sFlt-1/PlGF ratio for preeclampsia in twin pregnancies: a retrospective study
od: Satoshi Shinohara, i wsp.
Wydane: (2021-10-01)

Angiogenic factors (sFlt-1, PlGF) in twin pregnancy with placentaassociated complications
od: M. A. Kurtser, i wsp.
Wydane: (2022-11-01)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
od: Anna Maria Nuzzo, i wsp.
Wydane: (2021-01-01)

The sFlt1/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: a historical cohort study
od: Palma Dos Reis, CR, i wsp.
Wydane: (2023)

Relationship between the sFlt-1/PlGF ratio and the optical coherence tomographic features of chorioretina in patients with preeclampsia.
od: Jaekyoung Lee, i wsp.
Wydane: (2021-01-01)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian populationAJOG Global Reports at a Glance
od: Namrata Kumar, MD, MRCOG, EFOG, FACOG, i wsp.
Wydane: (2023-05-01)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
od: Vivek Pant, i wsp.
Wydane: (2019-07-01)

Differentiating Maternal Angiogenesis Factors between Early and Late Onset Preeclampsia: Higher sflt-1 in Early Onset Preeclampsia, Lower PlGF and Higher sflt-1/PlGF Ratio in Late Onset Preeclampsia
od: Joserizal Serudji, i wsp.
Wydane: (2024-11-01)

The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes
od: Yu-Shan Chang, i wsp.
Wydane: (2017-12-01)

Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?
od: Majed Alhudhud, i wsp.
Wydane: (2024-12-01)

Associations between Maternal sFlt-1/PlGF Ratio and Perinatal and Neonatal Outcomes in Newborns Born to Mothers with Preeclampsia
od: Hyo Ju Yang, i wsp.
Wydane: (2023-08-01)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
od: Szymon Kozłowski, i wsp.
Wydane: (2021-06-01)

The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants
od: Lisa Middendorf, i wsp.
Wydane: (2022-06-01)

Maternal PlGF and sFlt-1 are associated with low-birth-weight and/or small–for-gestational-age neonates in pregnancy with or without preeclampsia
od: Wenbo Luo, i wsp.

Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies
od: Alice Hoeller, i wsp.
Wydane: (2017-04-01)

Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice.
od: Stepan, H, i wsp.
Wydane: (2015)

Implementation of the sFlt‐1/PlGF ratio for prediction and diagnosis of pre‐eclampsia in singleton pregnancy: implications for clinical practice
od: Stepan, H, i wsp.
Wydane: (2015)

sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive statusAJOG Global Reports at a Glance
od: Easha Patel, MD, i wsp.
Wydane: (2024-08-01)

Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort
od: A. Iannaccone, i wsp.
Wydane: (2022-10-01)

sFlt-1/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation
od: Anne Dathan-Stumpf, i wsp.
Wydane: (2022-01-01)

sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients
od: Kamil Pluta, i wsp.
Wydane: (2024-01-01)

Análisis económico del cociente de preeclampsia sFlt- 1/PlGF comparado con el estándar de atención en Uruguay
od: Gonzalo Guiñazú, i wsp.
Wydane: (2024-09-01)

Перспективи використання sFlt-1, PlGF як біомаркерів прееклампсії, що приєдналася до хронічної гіпертензії
od: O.K. Popel, i wsp.
Wydane: (2022-11-01)

sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates
od: Jacek Witwicki, i wsp.
Wydane: (2021-08-01)

The sFlt-1/PlGF Ratio in Patients Affected by Gestational Diabetes and SARS-CoV-2 Infection
od: Daniela Denis Di Martino, i wsp.
Wydane: (2022-12-01)

Correlation between uterine artery Doppler and the sFlt-1/PlGF ratio in different phenotypes of placental dysfunction
od: Vesna Fabjan-Vodusek, i wsp.
Wydane: (2019-01-01)

Atypical preeclampsia before 20 weeks of gestation with multicystic placenta, hyperreactio luteinalis, and elevated sFlt-1/PlGF ratio as manifestations of fetal triploidy: A case report
od: Harue Hayashida, i wsp.
Wydane: (2022-01-01)

Аналіз перинатальних наслідків у жінок із високим і критичним рівнем співвідношення sFlt-1/PlGF
od: Yu.M. Duka, i wsp.
Wydane: (2023-03-01)

The Angiogenic Markers PlGF and sFlt-1 in Cytomegalovirus Infection During Pregnancy: Insights from a Clinical Case
od: Valentina Giardini, i wsp.
Wydane: (2025-02-01)

Predictive performance of PlGF (placental growth factor) for screening preeclampsia in asymptomatic women: A systematic review and meta-analysis
od: Agrawal, S, i wsp.
Wydane: (2019)